(111 days)
Not Found
No
The summary describes a traditional medical device (hip replacement components) and does not mention any software, algorithms, or AI/ML capabilities.
Yes
The Trinity Acetabular System is indicated for treating various degenerative joint diseases and correcting functional deformities related to the hip, which aligns with the definition of a therapeutic device designed to cure, mitigate, treat, or prevent disease.
No
The device is an implantable acetabular cup system used in total hip arthroplasty, not a tool for diagnosing medical conditions.
No
The device description explicitly details physical components like a titanium alloy shell, acetabular liners, modular heads, and femoral stems, indicating it is a hardware-based medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical implant for total hip arthroplasty to treat various hip conditions. This is a therapeutic device, not a diagnostic one.
- Device Description: The description details the components of a hip replacement system (shells, liners, heads, stems). These are physical implants used in surgery.
- Lack of Diagnostic Elements: There is no mention of analyzing samples from the human body (like blood, urine, tissue) or providing information for diagnosis.
- Performance Studies: The performance studies focus on the mechanical and material properties of the implant components (wear, fatigue, locking mechanisms, etc.), which are relevant to the function of a surgical device.
IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device does not fit that description.
N/A
Intended Use / Indications for Use
The Trinity Acetabular System is intended for use in total hip arthroplasty in skeletally mature patients, to provide increased mobility and reduce pain by replacing the damaged hip joint articulation where there is evidence of sufficient sound bone to seat and support the components.
The indications for the Trinity Acetabular System as a total hip arthroplasty include:
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
- Rheumatoid arthritis
- Correction of functional deformity
- Developmental dysplasia of the hip (DDH) or congenital dysplasia of the hip (CDH)
The Trinity Acetabular System is intended for cementless use only.
Product codes (comma separated list FDA assigned to the subject device)
LZO, MEH
Device Description
The Trinity Acetabular System is a modular acetabular cup system consisting of a press fit, titanium alloy shell, acetabular liners in neutral offset, +4mm offset, +4mm oblique, neutral 4mm EPW, ceramic and Co-Cr modular heads and titanium femoral stems.
The purpose of this submission is to add smaller acetabular shell sizes, highly crosslinked ultra-high molecular weight liners and large diameter Co-Cr and Biolox delta ceramic modular heads to the Trinity Acetabular System.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
hip joint
Indicated Patient Age Range
skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical testing conducted to demonstrate substantial equivalence includes: characterization of the HXLPE material, testing of the locking mechanisms between the Trinity Acetabular Shells and the HXLPE liners, range of motion analysis, impingement testing, wear testing, testing of shell stiffness, liner insertion and extraction testing, and burst, fatigue and axial pull-off testing of the Biolox delta ceramic heads.
Clinical testing was not necessary to determine substantial equivalence between the additional components of the Trinity Acetabular System and the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K093472, K091508, K994415, K010171, K033273, K103120, K992235, K100412
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.
0
MAY - 3 2011
510(K) SUMMARY 3.
| 1. Applicant/Sponsor: | Corin USA
10500 University Center Drive
Suite 190
Tampa, Florida 33612
Establishment Registration No.: |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. Contact Person: | Lucinda Gerber
Regulatory Affairs Associate
Corin USA
813-977-4469
lucinda.gerber@coringroup.com |
| 3. Proprietary Name: | Corin Trinity Acetabular System with HXLPE Liners |
| 4. Common Name: | Hip Prosthesis |
| 5. Classification Name: | Hip joint metal/ceramic/polymer semi-constrained cemented or
nonporous uncemented prosthesis (21CFR 888.3353) |
| 6. Legally Marketed Devices to which Substantial Equivalence is claimed: | Corin Trinity Acetabular System (K093472)Zimmer Continuum Acetabular System (K091508)DePuy Marathon Cross-Linked Polyethylene Liners (K994415,
K010171, K033273)Trinity Biolox delta Modular Heads (K103120)Zyranox Zirconia Ceramic Modular Heads (K992235)Smith & Nephew BIOLOX delta Ceramic Femoral Heads
(K100412) |
| 7. Device Description: | |
| The Trinity Acetabular System is a modular acetabular cup system consisting of a
press fit, titanium alloy shell, acetabular liners in neutral offset, +4mm offset, +4mm
oblique, neutral 4mm EPW, ceramic and Co-Cr modular heads and titanium femoral | |
stems.
The purpose of this submission is to add smaller acetabular shell sizes, highly crosslinked ultra-high molecular weight liners and large diameter Co-Cr and Biolox delta ceramic modular heads to the Trinity Acetabular System.
1
KI 006
The Trinity Acetabular System is intended for use in total hip arthroplasty in skeletally mature patients, to provide increased mobility and reduce pain by replacing the damaged hip joint articulation where there is evidence of sufficient sound bone to seat and support the components.
-
- Intended Use / Indications:
The indications for the Trinity Acetabular System as a total hip arthroplasty include:
- Intended Use / Indications:
-
Non-inflammatory degenerative joint disease including osteoarthritis and avascular 0 necrosis
-
Rheumatoid arthritis 0
-
Correction of functional deformity O
-
Developmental dysplasia of the hip (DDH) or congenital dysplasia of the hip (CDH) 0
The Trinity Acetabular System is intended for cementless use only.
-
- Summary of Technologies/Substantial Equivalence:
The additional components of the Trinity Acetabular System are similar to the predicate devices in terms of intended use and indications, materials, sizes, designs and performance. Based on these similarities, the additional components of the Trinity Acetabular System are believed to be substantially equivalent to the predicate devices.
- Summary of Technologies/Substantial Equivalence:
-
- Non-Clinical Testing:
Non-clinical testing conducted to demonstrate substantial equivalence includes: characterization of the HXLPE material, testing of the locking mechanisms between the Trinity Acetabular Shells and the HXLPE liners, range of motion analysis, impingement testing, wear testing, testing of shell stiffness, liner insertion and extraction testing, and burst, fatigue and axial pull-off testing of the Biolox delta ceramic heads.
- Non-Clinical Testing:
-
- Clinical Testing:
Clinical testing was not necessary to determine substantial equivalence between the additional components of the Trinity Acetabular System and the predicate devices.
- Clinical Testing:
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines forming its body and wings. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" in a circular arrangement.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Corin USA % Ms. Lucinda Gerber Regulatory Affairs Associate 10500 University Center Drive, Suite 190 Tampa, Florida 33612
MAY - 3 2011
Re: K110087
Trade/Device Name: Trinity Acetabular System Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: Class II Product Code: LZO, MEH Dated: April 28, 2011 Received: April 29, 2011
Dear Ms. Gerber:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
3
Page 2 - Ms. Lucinda Gerber
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
K.S. R. h.
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE 2.
11008
510(k) Number (if known): .
Device Name: Trinity Acetabular System
Indications for Use:
o
The indications for the Trinity Acetabular System as a total hip arthroplasty include:
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular O necrosis
- O Rheumatoid arthritis
- Correction of functional deformity O
- O Developmental dysplasia of the hip (DDH) or congenital dysplasia of the hip (CDH)
The Trinity Acetabular System is intended for cementless use only.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Ari M. Melleron
(Division Sign-Oft) (Division Sign-Sign-Sical, Orthopedic, and Restorative Devices
Page 1 of _1
510(k) Number K110087